Works matching IS 00070920 AND DT 2001 AND VI 85 AND IP 8

Results: 24

Identification of gene clusters differentially expressed during the cellular injury responses (CIR) to cisplatin.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1206, doi. 10.1054/bjoc.2001.2080

By:

Johnsson, A;
Byrne, P;
Bruin, R de;
Weiner, D;
Wong, J;
Los, G

Publication type:

Article

Chromosomal radiosensitivity in G<sub>2</sub>-phase lymphocytes identifies breast cancer patients with distinctive tumour characteristics.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1157, doi. 10.1054/bjoc.2001.2086

By:

Riches, A C;
Bryant, P E;
Steel, C M;
Gleig, A;
Robertson, A J;
Preece, P E;
Thompson, A M

Publication type:

Article

Dose and schedule-finding study of oral topotecan and weekly cisplatin in patients with recurrent ovarian cancer.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1124, doi. 10.1054/bjoc.2001.2014

By:

Gelderblom, H;
Sparreboom, A;
Jonge, M J A de;
Loos, W J;
Wilms, E;
Mantel, M A;
Hennis, B;
Camlett, I;
Verweij, J;
Burg, M E L van der

Publication type:

Article

Nucleolar damage correlates with neurotoxicity induced by different platinum drugs.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1219, doi. 10.1054/bjoc.2001.2024

By:

McKeage, M J;
Hsu, T;
Screnci, D;
Haddad, G;
Baguley, B C

Publication type:

Article

Loss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancer.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1168, doi. 10.1054/bjoc.2001.2041

By:

Müller-Tidow, C;
Kügler, K;
Diederichs, S;
Klümpen, S;
Möller, M;
Vogt, U;
Metzger, R;
Schneider, P M;
Berdel, W E;
Serve, H

Publication type:

Article

Cross-talk between signalling pathways and the multidrug resistant protein MDR-1.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1175, doi. 10.1054/bjoc.2001.2044

By:

Ding, S;
Chamberlain, M;
McLaren, A;
Goh, L-b;
Duncan, I;
Wolf, C R

Publication type:

Article

Effective cross-over to granisetron after failure to ondansetron, a randomized double blind study in patients failing ondansetron plus dexamethasone during the first 24 hours following highly emetogenic chemotherapy.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1099, doi. 10.1054/bjoc.2001.2045

By:

de Wit, R;
de Boer, A C;
vd Linden, G H M;
Stoter, G;
Sparreboom, A;
Verweij, J

Publication type:

Article

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1106, doi. 10.1054/bjoc.2001.2048

By:

Bottini, A;
Berruti, A;
Bersiga, A;
Brizzi, M P;
Bruzzi, P;
Aguggini, S;
Brunelli, A;
Bolsi, G;
Allevi, G;
Generali, D;
Betri, E;
Bertoli, G;
Alquati, P;
Dogliotti, L

Publication type:

Article

Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced non-small-cell lung cancer: A competing risks analysis.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1113, doi. 10.1054/bjoc.2001.2049

By:

Ataman, Ö U;
Bentzen, S M;
Saunders, M I;
Dische, S

Publication type:

Article

Sequential detection of alphafetoprotein-bearing cells in blood stem cell fraction of germ cell tumour patients.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1119, doi. 10.1054/bjoc.2001.2050

By:

Kasahara, T;
Hara, N;
Bilim, V;
Tomita, Y;
Saito, K;
Obara, K;
Takahashi, K

Publication type:

Article

Expression of hMLH1 is inactivated in the gastric adenomas with enhanced microsatellite instability.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1147, doi. 10.1054/bjoc.2001.2051

By:

Baek, M J;
Kang, H;
Kim, S E;
Park, J H;
Lee, J S;
Paik, Y-K;
Kim, H

Publication type:

Article

Profile of differentially expressed genes mediated by the type III epidermal growth factor receptor mutation expressed in a small-cell lung cancer cell line.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1211, doi. 10.1054/bjoc.2001.2053

By:

Pedersen, M W;
Thykjær, T;
Ørntoft, T F;
Damstrup, L;
Poulsen, H S

Publication type:

Article

Heparan sulfate proteoglycans and cancer.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1094, doi. 10.1054/bjoc.2001.2054

By:

Blackhall, F H;
Merry, C L R;
Davies, E J;
Jayson, G C

Publication type:

Article

Down-regulation of Fas-L in glioma cells by ribozyme reduces cell apoptosis, tumour-infiltrating cells, and liver damage but accelerates tumour formation in nude mice.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1185, doi. 10.1054/bjoc.2001.2055

By:

Chio, C-C;
Wang, Y-S;
Chen, Y-L;
Lin, S-J;
Yang, B-C

Publication type:

Article

A novel strategy for NQO1 (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1137, doi. 10.1054/bjoc.2001.2056

By:

Choudry, G A;
Stewart, P A Hamilton;
Double, J A;
Krul, M R L;
Naylor, B;
Flannigan, G M;
Shah, T K;
Brown, J E;
Phillips, R M

Publication type:

Article

Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1193, doi. 10.1054/bjoc.2001.2057

By:

Kos, J;
Sekirnik, A;
Kopitar, G;
Cimerman, N;
Kayser, K;
Stremmer, A;
Fiehn, W;
Werle, B

Publication type:

Article

Identification and characterization of a novel human hepatocellular carcinoma-associated gene.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1162, doi. 10.1054/bjoc.2001.2059

By:

Wang, Z-X;
Wang, H-Y;
Wu, M-C

Publication type:

Article

Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1201, doi. 10.1054/bjoc.2001.2062

By:

Staff, S;
Isola, J J;
Johannsson, O;
Borg, Å;
Tanner, M M

Publication type:

Article

Differential p53 protein expression in breast cancer fine needle aspirates: the potential for in vivo monitoring.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1102, doi. 10.1054/bjoc.2001.2064

By:

Ball, H M-L;
Hupp, T R;
Ziyaie, D;
Purdie, C A;
Kernohan, N M;
Thompson, A M

Publication type:

Article

IL-2 in combination with IFN-αand 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1130

By:

Atzpodien, J;
Kirchner, H;
Illiger, H J;
Metzner, B;
Ukena, D;
Schott, H;
Funke, P J;
Gramatzki, M;
Jürgenson, S von;
Wandert, T;
Patzelt, T;
Reitz, M

Publication type:

Article

Analysis of the TSC1and TSC2genes in sporadic renal cell carcinomas.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1226, doi. 10.1054/bjoc.2001.2072

By:

Parry, L;
Maynard, J H;
Patel, A;
Clifford, S C;
Morrissey, C;
Maher, E R;
Cheadle, J P;
Sampson, J R

Publication type:

Article

Measuring changes in human tumour vasculature in response to therapy using functional imaging techniques.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1085, doi. 10.1054/bjoc.2001.2077

By:

Anderson, H;
Price, P;
Blomley, M;
Leach, M O;
Workman, P

Publication type:

Article

CALENDAR.

Published in:: British Journal of Cancer, 2001, v. 85, n. 8, p. 1231, doi. 10.1054/bjoc.2000.2126
Publication type:: Article

The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas.

Published in:

British Journal of Cancer, 2001, v. 85, n. 8, p. 1153, doi. 10.1054/bjoc.2001.2085

By:

Andersson, S;
Rylander, E;
Strand, A;
Sällström, J;
Wilander, E

Publication type:

Article